Drug information of Toremifene
Mechanism of effect
Toremifene is a nonsteroidal triphenylethylene derivative. Toremifene binds to estrogen receptors and may exert estrogenic, antiestrogenic, or both activities, depending upon the duration of treatment, animal species, gender, target organ, or endpoint selected.
The antitumor effect of toremifene in breast cancer is believed to be mainly due to its antiestrogenic effects, in other words, its ability to compete with estrogen for binding sites in the cancer, blocking the growth-stimulating effects of estrogen in the tumor. Toremifene may also inhibit tumor growth through other mechanisms, such as induction of apoptosis, regulation of oncogene expression, and growth factors.
Toremifene is an antineoplastic hormonal agent primarily used in the treatment of advanced breast cancer. Toremifene is a nonsteroidal agent that has demonstrated potent antiestrogenic properties in animal test systems.
The antiestrogenic effects may be related to its ability to compete with estrogen for binding sites in target tissues such as breast.
- Half-Life: 5 days
- Peak Plasma Time: 3 hr
- Protein Bound: >99.5%
- Vd: 580 L
- Metabolism: Hepatic CYP3A4
- Metabolites: N-demethyltoremifene, (deamino-hydroxy) toremifene
- Clearance: 5 L/hr
- Excretion: Feces (primarily); urine (10%)
Adult : Breast Cancer
60 mg PO qDay until disease progresses
Side effectsedema , nausea , dizziness , vomiting , flushing , dry eyes , Cataracts , sweating , local thrombophlebitis
InteractionsCarbamazepine , Amitriptyline , Amiodarone , Erythromycin , Ofloxacin , Ondansetron , Imipramine , Clomipramine , Quinidine , Apomorphine , Procainamide , Mefloquine , Arsenic trioxide , Levofloxacin , Nortriptyline , Nilotinib , Haloperidol , Venlafaxine , Clarithromycin , Doxepin , Disopyramide , Sotalol , Sorafenib , Ciprofloxacin , Cisapride , Propafenone , Pimozide , Tacrolimus , Trazodone , Triptorelin , Thioridazine , dronedarone , Dolasetron , Palonosetron , vandetanib , sparfloxacin , Dofetilide , Goserelin , Promazine , Vasopressin , Halofantrine , Grepafloxacin , cobicistat , Delavirdine , Terfenadine , Abarelix , Asenapine , Alfuzosin , Pazopanib , Bendroflumethiazide , Perflutren , Pimavanserin , Apalutamide , Entrectinib , gilteritinib , glasdegib , oleandomycin , Bepridil , bedaquiline , Dasatinib , Gemtuzumab , vemurafenib , fluoroestradiol F 18 , sugammadex sodium
Prolongs QTc interval in a dose- and concentration-related manner
QT prolongation can result in Torsade de pointes, which may result in syncope, seizure, and/or death
Drugs known to prolong QT interval and strong CYP3A4 inhibitors should be avoided
Points of recommendation
Have blood work checked as you have been told by the doctor. Talk with the doctor.
Avoid grapefruit and grapefruit juice.
Use birth control that does not have hormones in it like a condom. Do this for as long as you take toremifene.
If you are pregnant or you get pregnant while taking toremifene, call your doctor right away.